Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Discover what you can learn with our compilation of resources to help expand your education around immuno-oncology. Explore books, clinical practice resources, learning tools, podcasts, videos, and more.
In August 2021, ONS brought together 17 oncology nurses to discuss their experiences with immuno-oncology, precision oncology, and nurse navigation. The goal was to assess their understanding of and identify gaps related to precision oncology and the role of the nurse navigator. This clinical update summarizes the findings of the focus group proceedings.
The drug reference sheets in ONS Voice are a quick guide to newly approved therapies or drugs with new indications. This resource from ONS clinical staff provides information through a nursing lens and includes the drug’s indication, side-effect profile, nursing considerations, patient education talking points, and more.
Tune in and tune up your practice with the Oncology Nursing Podcast. ONS’s popular podcast features weekly episodes with subject matter experts from all facets of oncology care.
Patients with uveal melanoma who were treated with tebentafusp, an investigational immunotherapy, lived a median 5.7 months longer than those in comparison groups, researchers reported in study findings presented at the American Association for Cancer Research 2021 annual meeting.
Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.
Patients with melanoma who consume a high-fiber diet during treatment with immune checkpoint inhibitors (ICIs) or anti-PD-1 therapy experience longer progression-free survival than those who don’t, researchers reported in Science. And probiotic supplementation, often considered a healthy behavior, reduces immunotherapy response.
Growing evidence suggests that the gut microbiome, a diverse and complex mix of microorganisms and their metabolites, is closely linked to the immune system, and researchers are studying whether modulating the gut microbiome affects cancer immunotherapy treatment outcomes. In particular, probiotics—which are flora typically obtained through dietary sources such as yogurt and fermented foods or via supplemental forms—are gaining prominence as a potential strategy to modulate the gut microbiome during cancer treatment.